Cargando…
New Insights into Neuroinflammation Involved in Pathogenic Mechanism of Alzheimer’s Disease and Its Potential for Therapeutic Intervention
Alzheimer’s disease (AD) is the most common form of dementia, affecting more than 50 million people worldwide with an estimated increase to 139 million people by 2050. The exact pathogenic mechanisms of AD remain elusive, resulting in the fact that the current therapeutics solely focus on symptomati...
Autores principales: | Li, Tiantian, Lu, Li, Pember, Eloise, Li, Xinuo, Zhang, Bocheng, Zhu, Zheying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221885/ https://www.ncbi.nlm.nih.gov/pubmed/35741054 http://dx.doi.org/10.3390/cells11121925 |
Ejemplares similares
-
Methylprednisolone alleviates cognitive functions through the regulation of neuroinflammation in Alzheimer’s disease
por: Sun, Yuan, et al.
Publicado: (2023) -
Hydrocortisone Mitigates Alzheimer’s-Related Cognitive Decline through Modulating Oxidative Stress and Neuroinflammation
por: Li, Jinran, et al.
Publicado: (2023) -
Asiaticoside Mitigates Alzheimer’s Disease Pathology by Attenuating Inflammation and Enhancing Synaptic Function
por: Liu, Sai, et al.
Publicado: (2023) -
Development of p-Tau Differentiated Cell Model of Alzheimer’s Disease to Screen Novel Acetylcholinesterase Inhibitors
por: Uras, Giuseppe, et al.
Publicado: (2022) -
Alzheimer's Disease Blood Biomarkers Associated With Neuroinflammation as Therapeutic Targets for Early Personalized Intervention
por: Oh, Sher Li, et al.
Publicado: (2022)